Skip to content

Study · Observational study · n = 63,270 · 2018

1 result

The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8 years.

Gilsenan A, Harding A, Kellier-Steele N, Harris D, Midkiff K, Andrews E

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA5 Jul 2018Cited by 38 (Europe PMC)

PMID29978254 (opens in a new tab)PMCIDPMC6154045 (opens in a new tab)DOI10.1007/s00198-018-4604-8 (opens in a new tab)PepBankPUB-29978254
Read at sourcePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanObservational studySafety outcome

    In the teriparatide patient registry, no incident osteosarcoma cases were identified through the eighth annual cancer registry linkage.

    In plain wordsAmong registered teriparatide users, cancer registry linkage found no new osteosarcoma cases.

    Peptide
    Teriparatide (PTH 1-34)
    Outcome
    Not applicableIncident osteosarcoma
    Study

    n = 63,270

    Outcome group
    Adverse events · Cancer
    Studied dose
    Dose not stated

    Source sentences

    Summary
    To date, no incident cases of osteosarcoma have been identified among patients registered in the FPR.
    4 context sentences
    Summary · context
    The Forteo Patient Registry (FPR) was established in 2009 to estimate the incidence of osteosarcoma in US patients treated with teriparatide.
    Summary · context
    The FPR is a prospective US registry designed to link data from participants annually with state cancer registries.
    Summary · context
    For the eighth annual linkage in 2017, information necessary for linkage with 63,270 patients in the FPR was submitted to each of the 42 participating registries.
    Summary · context
    These patients contributed approximately 242,782 person-years of follow-up.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.